Template:Percutaneous Coronary Intervention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 442: | Line 442: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
:[[Percutaneous coronary intervention proton pump inhibitors and anti-platelet therapy|Proton Pump Inhibitors and Antiplatelet Therapy]] | |||
|- | |- | ||
! | ! | ||
Line 448: | Line 448: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
:[[Percutaneous coronary intervention clopidogrel genetic testing|Clopidogrel Genetic Testing]] | |||
|- | |- | ||
! | ! | ||
Line 454: | Line 454: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
:[[Percutaneous coronary intervention platelet function testing|Platelet Function Testing]] | |||
|- | |- | ||
! | ! |
Revision as of 23:53, 18 October 2012
Percutaneous Coronary Intervention Microchapters |
Guideline Recommendations |
---|
CAD Revascularization: |
Pre-procedural Considerations: |
Procedural Considerations: |
|
|
|
|
|
|
|
|
|
Post-Procedural Considerations: |
Quality and Performance Considerations: |
Percutaneous Coronary Intervention On the Web |
American Roentgen Ray Society Images of Percutaneous Coronary Intervention |
Directions to Hospitals Treating Percutaneous Coronary Intervention |
Risk calculators and risk factors for Percutaneous Coronary Intervention |